📊 Are you in? These 9 AI-picked stocks are up 10%+Pick Stocks with AI

Moderna And Volatility Index Flashing A Warning

Published 05/20/2020, 12:37 AM

VXX Daily Chart

A warning does not necessarily have to become a full-blown sign to head for the exits. But it is, nevertheless, a warning.

The last time I saw a warning from the iPath® Series B S&P 500® VIX Short-Term Futures™ ETN (NYSE:VXX) or the Volatility ETF, was in February.

Granted, on February 5th, the title of my daily post was “Volatility’s Inverted Hammer Doji Warning to Bulls,” and the current technical pattern is a bit different.

On Monday VXX had an inverted hammer doji pattern, while yesterday, VXX rallied and closed back over a key weekly exponential moving average. This does not surprise me either.

In early February, complacency ruled the day. Today, we are forewarned, hence forearmed.

Back in February I wrote:

“Although the last couple of days brought back euphoria into the market, with volatility hanging tough, one should be prepared for anything.”

And so it goes today.

With hopes of a vaccine, Moderna (NASDAQ:MRNA) ran up the market indices by over 5% in just 1 ½ days. In February, the stock traded at near $20 with a market cap of less than $10 billion.

In 4 months, the stock price rose to over $80 a share and the market cap increased by $26.61 billion. So typical of the recent market action.

Headlines drive price up by 500 points and down by 500 points as quickly as one can say vaccine. But the volatility index is smarter.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads.

Even with the market trying to move beyond the resistance levels from April, VXX barely budged. It’s as if VXX knew that Moderna lacked key data needed to legitimize its progress on the vaccine.

VXX is in a caution phase and has a gap to fill at 36.60. That is the area we will be watching.

Key Levels

S&P 500 (SPDR S&P 500 (NYSE:SPY)  299.42 resistance with 288.30 support

Russell 2000 (iShares Russell 2000 ETF (NYSE:IWM)) 127.75 support with resistance 136.85

Dow (SPDR® Dow Jones Industrial Average ETF Trust (NYSE:DIA)) 239.50 support with resistance at 247.67

NASDAQ (Invesco (NYSE:IVZ) QQQ Trust (NASDAQ:QQQ)) Filled the gap to 229.32, then sold off. 223.50 support

SPDR® S&P Regional Banking ETF (NYSE:KRE) (Regional Banks) Prodigal doing prodigal-run and then slump back. 33.15 support

VanEck Vectors Semiconductor ETF (NYSE:SMH) (Semiconductors) 140 resistance 134 support

iShares Transportation Average ETF (NYSE:IYT) (Transportation) 150 resistance 140 support

iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) (Biotechnology) A key reversal failure pattern today

SPDR® S&P Retail ETF (NYSE:XRT) (Retail) Could not hold 38.50 so looking 37.20 support

Volatility Index (VXX) 36.60 resistance to clear

Junk Bonds (SPDR® Bloomberg Barclays (LON:BARC) High Yield Bond ETF (NYSE:JNK)) 100 resistance 97.50 support

High Yield Bonds (iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSE:LQD)) 130 resistance 127.50

Which stock should you buy in your very next trade?

AI computing powers are changing the stock market. Investing.com's ProPicks AI includes 6 winning stock portfolios chosen by our advanced AI. In 2024 alone, ProPicks AI identified 2 stocks that surged over 150%, 4 additional stocks that leaped over 30%, and 3 more that climbed over 25%. Which stock will be the next to soar?

Unlock ProPicks AI
Read Next

Latest comments

MunchMacMay 20, 2020, 20:14
Good insights about vix.
Thomas DeVitoMay 20, 2020, 09:23
it's dropped mid week almost every week. I think Wall Street understands what phase 1 means. It's retail rushing in and leaving.
SPX TraderMay 20, 2020, 10:42
The massive selloff at the end of the day was not caused by retail. Wall Street got wind of it first and markets sold off immediately. The people who took Moderna's secondary offering at $76 was Wall Street too and they were caught off-guard as well.
Thomas DeVitoMay 22, 2020, 12:20
 If you say so. Wall Street is letting retail control the market right now. I find it hard to believe that the big investors don't have biotech experts on their analysis teams. If Wall Street was annoyed about anything it was that an IPO diluted their shares.
Thomas DeVitoMay 22, 2020, 12:21
*offering I meant
Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.